Difference between revisions of "Part:BBa K1993028"
LittleCloud (Talk | contribs) |
|||
Line 4: | Line 4: | ||
<h2>'''Functions:'''</h2> | <h2>'''Functions:'''</h2> | ||
− | With the purpose of increasing homing efficiency of MSCs and illustrating their distribution, we constructed a plasmid | + | With the purpose of increasing homing efficiency of MSCs and illustrating their distribution, we constructed a plasmid BBa_K1993028 under the control of EF-1α. (Figure 1) After that, plasmid BBa_K1993028 would be transduced into MSCs by lentivirus expression vector. What’s more, we confirmed its function in vitro and in vivo (delayed type hypersensitivity animal models, DTH). |
<html> | <html> | ||
Line 83: | Line 83: | ||
'''Figure8''' | '''Figure8''' | ||
<br> | <br> | ||
− | + | The inflamed ears were collected from each group and subjected to in situ immunofluorescence staining. Our results revealed that MSC<sup>CXCR5</sup> exhibited enhanced capacities for targeted migration to the ears in DTH model. | |
Line 111: | Line 111: | ||
<br> | <br> | ||
Ear sampling for quantitative PCR analysis. Comparing with DTH+MSCs group, levels of anti-inflammatory cytokines (IL-10) elevated in DTH+MSC<sup>CXCR5</sup> group, while levels of pro-inflammatory cytokines (IL-4, TNF-α, IFN-γ, IL-6 and IL-17) decreased in DTH+MSC<sup>CXCR5</sup> group. | Ear sampling for quantitative PCR analysis. Comparing with DTH+MSCs group, levels of anti-inflammatory cytokines (IL-10) elevated in DTH+MSC<sup>CXCR5</sup> group, while levels of pro-inflammatory cytokines (IL-4, TNF-α, IFN-γ, IL-6 and IL-17) decreased in DTH+MSC<sup>CXCR5</sup> group. | ||
− | '''In a word, | + | '''In a word, MSCs<sup>CXCR5</sup> displayed greater immunoregulatory effect.''' |
<li><br> | <li><br> | ||
Line 128: | Line 128: | ||
<br> | <br> | ||
After injection, MSC<sup>CXCR5</sup> displayed better treatment efficacy than MSC<sup>eGFP</sup>, characterized by their abilities to decrease ear thickness and leukocyte infiltration. MSC<sup>CXCR5</sup> significantly attenuated DTH as early as 24 hours post-injection, and had even greater effects at 48 hours post-injection. | After injection, MSC<sup>CXCR5</sup> displayed better treatment efficacy than MSC<sup>eGFP</sup>, characterized by their abilities to decrease ear thickness and leukocyte infiltration. MSC<sup>CXCR5</sup> significantly attenuated DTH as early as 24 hours post-injection, and had even greater effects at 48 hours post-injection. | ||
− | '''In a word, | + | '''In a word, MSCs<sup>CXCR5</sup> regulated immune system in inflammatory condition in a more significant way.''' |
<br> | <br> |
Latest revision as of 12:55, 18 October 2016
CXCR5-IRES-eGFP
Functions:
With the purpose of increasing homing efficiency of MSCs and illustrating their distribution, we constructed a plasmid BBa_K1993028 under the control of EF-1α. (Figure 1) After that, plasmid BBa_K1993028 would be transduced into MSCs by lentivirus expression vector. What’s more, we confirmed its function in vitro and in vivo (delayed type hypersensitivity animal models, DTH).
Figure 1 EF-1α-CXCR5-IRES-eGFP
Details:
- Elongation factor-1α (EF-1α), a constitutive promoter, is responsible for mediating the recruitment of aminoacyl-tRNA to the A-site of the 80S ribosome during protein synthesis.
- CXCR5 is a chemokine receptor and its corresponding ligand is CXCL13. (Details could be seen on BBa_K1993013)
- Internal ribosome entry site (IRES) is an RNA element that allows for translation initiation in an end-independent manner, as part of the greater process of protein synthesis. (Details could be seen on BBa_K1993016)
- eGFP dramatically improved the spectral characteristics of GFP and allowed the practical use of GFP in mammalian cells. (Details could be seen on BBa_K1993017)
Results:
In vitro
-
Figure 2 Figure 3 -
Figure 4 Figure 5 -
Figure 6 Figure 7
In vivo
Figure8
The inflamed ears were collected from each group and subjected to in situ immunofluorescence staining. Our results revealed that MSCCXCR5 exhibited enhanced capacities for targeted migration to the ears in DTH model.
Figure9
The inflamed ears were collected from each group, subjected to in situ immunofluorescence staining and observed under fluorescence microscope. Our results revealed MSCCXCR5 could be located in the inflamed ears of DTH mice.
Figure 10
Ear sampling for quantitative PCR analysis. Comparing with DTH+MSCs group, levels of anti-inflammatory cytokines (IL-10) elevated in DTH+MSCCXCR5 group, while levels of pro-inflammatory cytokines (IL-4, TNF-α, IFN-γ, IL-6 and IL-17) decreased in DTH+MSCCXCR5 group. In a word, MSCsCXCR5 displayed greater immunoregulatory effect.
Figure 11
Figure 12
After injection, MSCCXCR5 displayed better treatment efficacy than MSCeGFP, characterized by their abilities to decrease ear thickness and leukocyte infiltration. MSCCXCR5 significantly attenuated DTH as early as 24 hours post-injection, and had even greater effects at 48 hours post-injection. In a word, MSCsCXCR5 regulated immune system in inflammatory condition in a more significant way.
Sequence and FeaturesAssembly Compatibility:- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21INCOMPATIBLE WITH RFC[21]Illegal XhoI site found at 31
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal NgoMIV site found at 973
- 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI.rc site found at 259
Illegal SapI site found at 1050
- 10